A study found a statistically significant association between 18F-FDG uptake and PD-L1 expression in malignant tissues; this suggests that PET/CT may play an important role in the selection of ovarian cancer patients for anti-PD-L1 antibody therapy [21]. Here, CD274 is linked to ovarian cancer.